Maria C. Freire - Feb 14, 2025 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
Director
Signature
/s/ Nina Ayer, Attorney in Fact
Stock symbol
EXEL
Transactions as of
Feb 14, 2025
Transactions value $
-$591,822
Form type
4
Date filed
2/19/2025, 08:31 PM
Previous filing
Jan 17, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Options Exercise $325K +15.9K +17.44% $20.50 107K Feb 14, 2025 Direct F1
transaction EXEL Common Stock Options Exercise $624K +28.2K +26.42% $22.10 135K Feb 14, 2025 Direct F1
transaction EXEL Common Stock Sale -$1.54M -44.1K -32.65% $34.94 91K Feb 14, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXEL Option (right to buy) Options Exercise $0 -15.9K -100% $0.00 0 Feb 14, 2025 Common Stock 15.9K $20.50 Direct F3
transaction EXEL Option (right to buy) Options Exercise $0 -28.2K -100% $0.00 0 Feb 14, 2025 Common Stock 28.2K $22.10 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 18,838 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F2 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $34.92 to $35.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3 The option, representing the right to purchase a total of 15,874 shares of Common Stock, became fully exercisable on May 24, 2018.
F4 The option, representing the right to purchase a total of 28,240 shares of Common Stock, became fully exercisable on April 5, 2018.